MedPage Today on MSN
FDA Approves Mitapivat for Thalassemia-Related Anemia
An oral pyruvate kinase (PK) activator, mitapivat becomes the only approved option for treating anemia in both ...
Shares of Agios Pharmaceuticals jumped nearly 12% premarket on Wednesday after the U.S. Food and Drug Administration approved ...
Agios Pharmaceuticals has announced a major regulatory milestone with the U.S. Food and Drug Administration approving ...
MedPage Today on MSN
FDA Approves First Oral Medication for Iron Deficiency in Kids
The FDA has expanded the indication of ferric maltol (Accrufer) capsules for the treatment of iron deficiency to include ...
Oats contain fiber that helps support heart and digestive health. Oats contain a compound similar to gluten, so people with gluten allergies may want to avoid them.
A new genome-wide mapping method finally shows how thousands of genes connect to drive disease. Biomedical researchers are working intensively to identify the genes that contribute to disease, with ...
Agios Pharmaceuticals shares surged after the FDA approved expanded use of its drug mitapivat for treating anemia in alpha- and beta-thalassemia patients.
Learn more about whether Masimo Corporation or Omnicell, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
When we talk about essential minerals that help shape the human body, iron plays a key role. It is said to be a key component ...
Vitamin B6 deficiency symptoms include mood changes, mouth sores, skin lesions, nerve damage, loss of muscle control, seizures, and more.
The Food and Drug Administration (FDA) has expanded the approval of Jascayd ® (nerandomilast), an oral phosphodiesterase 4 inhibitor, to include treatment of progressive pulmonary fibrosis (PPF) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results